Drug therapy for pulmonary nontuberculous mycobacterial disease

Ho Namkoong, Naoki Hasegawa

研究成果: Article査読

抄録

A definite strategy for pulmonary nontuberculous mycobacterial (NTM) disease has not been established yet. For this reason, pulmonary physicians are frequently distressed in the clinical setting. The standard chemotherapy agents used for pulmonary Mycobacterium avium complex, the most common NTM in Japan, are clarithromycin, rifampicin, and ethambutol. In this manuscript as well as in the standard chemotherapy for pulmonary NTM disease, we review various clinical problems that are not included in the guidelines and new drugs that are expected to be launched in the future.

本文言語English
ページ(範囲)1084-1094
ページ数11
ジャーナルJapanese Journal of Chest Diseases
74
10
出版ステータスPublished - 2015 10月

ASJC Scopus subject areas

  • 呼吸器内科

フィンガープリント

「Drug therapy for pulmonary nontuberculous mycobacterial disease」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル